Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary novel drugs.
Financial Results:
Jubilant Pharmova Ltd reported Revenues for Q4FY25 of ₹1,929.00 Crores up from ₹1,759.00 Crore year on year, a rise of 9.66%.
Total Expenses for Q4FY25 of ₹1,732.00 Crores up from ₹1,661.00 Crores year on year, a rise of 4.27%.
Consolidated Net Profit of ₹151.00 Crores from -₹62.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹9.64, from -₹3.68 in the same quarter of the previous year.